Enovix Corporation (NASDAQ:ENVX – Get Free Report) gapped down prior to trading on Monday after William Blair downgraded the stock from an outperform rating to a market perform rating. The stock had previously closed at $4.39, but opened at $3.92. Enovix shares last traded at $3.6250, with a volume of 4,544,490 shares.
Several other research firms also recently issued reports on ENVX. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 price objective on shares of Enovix in a report on Thursday. Canaccord Genuity Group lowered their target price on shares of Enovix from $15.00 to $10.00 and set a “buy” rating for the company in a research note on Friday. B. Riley Financial dropped their target price on shares of Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a research report on Thursday. JPMorgan Chase & Co. lowered shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Finally, Benchmark decreased their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Enovix currently has an average rating of “Hold” and an average price target of $11.86.
Read Our Latest Report on Enovix
Institutional Inflows and Outflows
Enovix Trading Down 17.9%
The firm has a market cap of $785.78 million, a price-to-earnings ratio of -4.45 and a beta of 2.32. The company has a fifty day moving average price of $5.33 and a 200-day moving average price of $5.86. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46.
Enovix (NASDAQ:ENVX – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.02. The firm had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.Enovix’s revenue for the quarter was up 20.8% compared to the same quarter last year. During the same period last year, the company earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, research analysts expect that Enovix Corporation will post -0.78 EPS for the current year.
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Further Reading
- Five stocks we like better than Enovix
- 5 Recession-Proof Stocks Hiding in Cardboard Boxes
- These 5 Dividend Stocks Show Why Income Investing Still Matters
- The Quantum Race Is Heating Up—And 2 Small Players Stand Out
- 3 Robotics Stocks Under $10: Value, Momentum, or Bet?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
